Assessing the influence of biological sex and pregnancy on disability of multiple sclerosis patients
Multiple Sclerosis Journal – Experimental, Translational and Clinical · 2026-10 · 12 (4)
DOI: 10.1177/20552173261505622 ↗Kurz gefasst
Fachartikel in der Zeitschrift Multiple Sclerosis Journal – Experimental, Translational and Clinical, online erschienen am 17.11.2026. Verfasst von Farzana Jahan und 39 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background and objectives Biological sex, hormonal influences and pregnancy-related immune changes may affect disability progression in multiple sclerosis (MS), but large longitudinal evidence is limited. This study examined the association between sex, pregnancy history and disability using MSBase registry data.
Methods
Data from 537,582 visits across 16 countries were analysed, with 1–126 visits per patient. Disability was measured using the Expanded Disability Status Scale (EDSS), modelled as a standardised z-score. Hierarchical generalised additive mixed models were fitted separately by country, adjusting for confounders, with pooled estimates from random-effects meta-analysis. Analyses compared (1) males vs females and (2) males, females ever pregnant and females never pregnant (reference).
Results
Males were associated with higher disability than females (95% CI: 0.103,0.184). In the three-group model, males were associated with higher disability (95% CI: 0.036, 0.146), while females with a history of pregnancy were associated with lower disability (95% CI: −0.238,−0.108) compared with females who had never been pregnant. Differences corresponded to approximately 0.2–0.4 EDSS points, indicating relatively modest differences in absolute disability.
Conclusions
Biological sex and pregnancy history were associated with MS disability. Although modest, these differences may accumulate over time, suggesting reproductive history is an important factor in MS outcomes, but one cannot make any causal interpretation from these results.
Zitieren
APA
Jahan, F., Ullah, I., Jokubaitis, V., Butzkueven, H., Patti, F., Weinstock-Guttman, B., Tomassini, V., Lugaresi, A., Kalincik, T., Khoury, S. J., Sá, M. J., John, N., Altintas, A., Soysal, A., Oreja-Guevara, C., Fabis-Pedrini, M., Lalive, P., Shaw, C., Moore, F., …, & Wijmeersch, B. V. (2026). Assessing the influence of biological sex and pregnancy on disability of multiple sclerosis patients. Multiple Sclerosis Journal – Experimental, Translational and Clinical, 12(4). https://doi.org/10.1177/20552173261505622
Vancouver
Jahan F, Ullah I, Jokubaitis V, Butzkueven H, Patti F, Weinstock-Guttman B, et al. Assessing the influence of biological sex and pregnancy on disability of multiple sclerosis patients. Multiple Sclerosis Journal – Experimental, Translational and Clinical. 2026;12(4). doi:10.1177/20552173261505622
BibTeX
@article{Jahan2026,
author = {Jahan, Farzana and Ullah, Insha and Jokubaitis, Vilija and Butzkueven, Helmut and Patti, Francesco and Weinstock-Guttman, Bianca and Tomassini, Valentina and Lugaresi, Alessandra and Kalincik, Tomas and Khoury, Samia J and Sá, Maria José and John, Nevin and Altintas, Ayse and Soysal, Aysun and Oreja-Guevara, Celia and Fabis-Pedrini, Marzena and Lalive, Patrice and Shaw, Cameron and Moore, Fraser and Ozakbas, Serkan and Eichau, Sara and Girard, Marc and Alroughani, Raed and Amato, Maria Pia and Grammond, Pierre and Buzzard, Katherine and Gerlach, Oliver and Yamout, Bassem and Pesch, Vincent van and Karabudak, Rana and Maimone, Davide and Kuhle, Jens and Cartechini, Elisabetta and Walt, Anneke van der and Ampapa, Radek and Ramo-Tello, Cristina and Gans, Koen de and Spitaleri, Daniele and Gregorio, Maria Di and Wijmeersch, Bart Van},
title = {Assessing the influence of biological sex and pregnancy on disability of multiple sclerosis patients},
journal = {Multiple Sclerosis Journal – Experimental, Translational and Clinical},
year = {2026},
volume = {12},
number = {4},
doi = {10.1177/20552173261505622}
}
EUVIMED